The Role of Serotonin in the Human Brain
Various physiological functions are modulated by the neurotransmitter 5-hydroxytryptamine, also known as serotonin. It plays an important role in many of our bodily processes, including mood, reward, cognition, and learning.
The biological functions of gut-derived serotonin (GDS) include regulation of erythropoiesis, synthesis, and secretion. In addition, GDS has been shown to bind to multiple receptors during intestinal inflammatory conditions. In this way, GDS is a potential therapeutic strategy for intestinal diseases.
It has been known that the production of gut-derived 5-HT is mainly regulated by indigenous spore-forming bacteria. These bacteria, such as Clostridia and Turicibacter sanguinis, can induce the production of serotonin by metabolites they produce. These metabolites modulate many physiological functions, including glucose homeostasis, epithelial development, and intestinal motility.
A study conducted in mice found that blocking the production of serotonin improved insulin tolerance in Type 2 diabetic mice. The reduction in blood serotonin levels in the mutant mice was only about half of what was observed in normal mice. However, in old ovariectomized mice, blocking the production of serotonin significantly increased bone formation.
These results indicate that inhibiting the production of gut-derived serotonin may be a novel approach to treating osteoporosis. In addition, reducing the production of serotonin can also affect the expression of several transcription factors. These factors control various aspects of cellular growth, proliferation, and differentiation. Therefore, GDS may have a direct and pronounced effect on bone formation.
Studies have demonstrated that gut-derived serotonin, or 5-HT, plays a critical role in the regulation of intestinal inflammation. In this regard, the presence of intestinal microbiota is a critical factor in the production of serotonin. Normally, serotonin is associated with well-being. But impaired serotonin homeostasis can lead to a variety of neurological disorders. It has been proposed that the imbalance in serotonin levels in the gastrointestinal tract might be a contributing cause of irritable bowel syndrome.
Several types of cells exist within the blood-brain barrier. These cell types interact with each other in concert to protect the CNS from microorganisms in the bloodstream.
These cells include enterochromaffin cells, which coordinate basolateral communication in the GI tract. These cells also play an important role in regulating a variety of gut physiological processes. For example, they may regulate chemo/mechanosensation, nutrient absorption, and secretion.
Serotonin is produced by various cell types throughout the periphery. However, most of the serotonin is produced by enterochromaffin cells. These cells produce up to 95% of the total body’s serotonin.
The synthesis of serotonin in the brain involves the expression of several rate-limiting enzymes. B cells have a high level of these enzymes, which are expressed in both the CNS and the peripheral tissues. During pregnancy, the mass of these cells increases, resulting in increased secretion of serotonin.
Serotonin also regulates glucose metabolism. It acts through a receptor, Htr2b, on hepatocytes, promoting glycolysis. It also inhibits the lipopolysaccharide-induced secretion of pro-inflammatory cytokines. This effect may be due to the inhibition of glucose uptake.
In recent years, there has been interest in serotonin’s immunoregulatory role. These effects are mediated through at least fourteen receptors. These receptors are divided into four subfamilies, each with different coupling to different G-proteins. Each subfamily also regulates its own physiological functions.
Peripheral serotonin is produced by multiple cell types, including macrophages and neutrophils. It has been suggested that peripheral serotonin plays a role in the development of inflammatory diseases. It is also believed that peripheral serotonin is a regulator of glucose homeostasis. This role is not fully understood, but it may influence the storage of nutrients and affect hepatic lipid metabolism.
Various studies have suggested that the brain and gut microbiota interact with one another. This interaction can be bidirectional and affect cognitive, emotional and behavioral dimensions of health. It has been suggested that this communication might be linked to the hypothalamic-pituitary-adrenal (HPA) axis. This axis plays an important role in regulating the synthesis of stress-related hormones. It also plays a role in determining the level of neurotransmitters in the body.
In this study, we investigated the potential of the HPA axis and gut microbiota in a number of behavioral processes. These include cognition, anxiety, and mood. We evaluated the possible influence of the gut microbiota on the HPA axis and the brain. This may have implications for treatments for certain psychiatric disorders. We also evaluated the potential of potential probiotics to alter the brain’s neurochemistry and behaviors.
The gut microbiota has been found to influence brain functions, moods, and neurotransmitters. It is also believed to impact the endocrine/immune system. A variety of probiotics are thought to have a neurochemical anxiolytic effect on the central nervous system. These effects might be useful in preventing and treating anxiety and depression.
The HPA axis has long been associated with suicide. Research has suggested that a high level of cortisol reactivity to stress may play a role in suicidal behavior. It has also been suggested that there is an association between early life adversity and the development of stress-related problems.
Several classes of drugs target the 5-HT system. There are psychedelic drugs, empathogens, and antiemetic drugs. The serotonin 5HT6R is an ideal drug target in the treatment of Alzheimer’s disease (AD) and other neurodegenerative diseases. Inhibition of the 5HT6R is thought to reverse pharmacologically induced cognitive deficits. The most recent studies on the subject have been focused on the neuronal and cellular mechanisms underlying the effect.
The 5-HT6R is a member of the GPCR (G protein-coupled receptor) superfamily. This family of receptors is responsible for the production of a host of neurotransmitters including acetylcholine, glutamate, and acetylneuraminic acid. It has been hypothesized that the 5HT6R plays a role in cognition, especially in memory and learning.
The 5-HT6R is most prominently expressed in the striatum, cerebellum, hippocampus, and nucleus accumbens, which are thought to play an important role in learning and memory. One of the more interesting properties of the 5HT6R is its ability to enhance cognitive functions through multiple neurotransmitter pathways. Its major roles include activating the hERG channel and stimulating the release of glutamate. Inhibition of the 5HT6R also reduces serotonin levels, which may help explain its efficacy as an antidepressant.
The 5-HT6R is the star of the show, but it is not the only gimmick. A recent study has demonstrated the effectiveness of a single-dose oral administration of a novel compound in improving memory and cognition in rats. This compound exhibited procognitive effects in a test similar to a well-established memory enhancer, tacrine.
Receptors and transporters
Biologically, the serotonin system is composed of a variety of receptors and transporters. These are responsible for serotonin’s action on a variety of physiological processes. In addition to its pharmacological role, serotonin plays a key role in mood regulation, including depression and anxiety. In fact, recent evidence suggests that the antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) may depend on the modulation of the inhibitory serotonin autoreceptors.
These proteins are also involved in epithelial development and gastrointestinal motility. The receptors and transporters are important targets of many drugs and have been increasingly utilized in therapeutic approaches to treat depression, anxiety, and other psychiatric disorders.
The receptors and transporters of the serotonin system are characterized by a structural diversity that is the result of alternative splicing and allelic polymorphism. The resulting receptors and transporters are divided into seven classes. Some are G-protein-coupled receptors, while others are vesicular monoamine transporters. The structure of the G protein-coupled receptor is composed of seven alpha helices.
In humans, there are a total of 15 distinct forms of the receptor. Some are produced by alternative splicing, and others are produced by editing the pre-mRNA. These variants are associated with different functions, and these variations may explain behavioral differences between individuals.
In this review, we summarize the current state of research on the pharmacology of the five serotonin receptors and the related transporters. These studies have provided a better understanding of the molecular mechanisms of serotonin signaling and their functional importance in the human body.
Pathways in the brain
Thousands of neurons in the brain use serotonin to modulate a range of behaviors. It is a monoamine neurotransmitter that plays a key role in appetite, mood, sleep, anxiety, and other behaviors. Several studies have shown that problems in the brain’s serotonin system are associated with various psychiatric disorders.
The brain’s serotonin system is made up of multiple subpopulations, all working in concert. The synthesis and release of serotonin depend on the availability of tryptophan, a key amino acid. The neuronal cell bodies that produce and release serotonin are located in the brainstem and spinal cord. There are two main groups of these neuronal cell bodies. They are the rostral group and the caudal group. Each of these groups has its own afferent projections.
The rostral group of 5-HT neurons produces fibers that ascend to the forebrain. The medial forebrain bundle carries these fibers to a variety of target areas, including the medial cortex, hippocampus, septum, cingulum, and lateral cortex.
The brain’s reward pathway begins in the ventral tegmental area, and it ends in the nucleus accumbens, where dopamine primarily mediates feelings of pleasure. Dopamine is also responsible for motor function. It’s one of the most widely studied neurotransmitters, and most drugs of abuse will interfere with its signaling.
Dopamine is primarily involved in motivating behavior. It’s also the neurotransmitter that triggers the reward pathway. In addition to these two pathways, other key pathways also rely on dopamine.
Health A to Z. (n.d.). HSE.ie. https://www2.hse.ie/az/
U.S. National Library of Medicine. (n.d.). https://www.ncbi.nlm.nih.gov/
Directory Health Topics. (n.d.). https://www.healthline.com/directory/topics
Health A-Z. (2022, April 26). Verywell Health. https://www.verywellhealth.com/health-a-z-4014770
Harvard Health. (2015, November 17). Health A to Z. https://www.health.harvard.edu/health-a-to-z
Health Conditions A-Z Sitemap. (n.d.). EverydayHealth.com. https://www.everydayhealth.com/conditions/